Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib

Hepatocellular carcinoma (HCC) is the third-leading cause of cancer-related death with limited treatment options and frequent resistance to sorafenib, the only drug currently approved for first-line therapy. Therefore, better understanding of HCC tumor biology and its resistance to treatment is urge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Quintavalle, Cristina, Hindupur, Sravanth Kumar, Quagliata, Luca, Pallante, Pierlorenzo, Nigro, Cecilia, Condorelli, Gerolama, Andersen, Jesper Bøje, Tagscherer, Katrin Elisabeth, Roth, Wilfried, Beguinot, Francesco, Heim, Markus Hermann, Ng, Charlotte Kiu Yan, Piscuoglio, Salvatore, Matter, Matthias Sebastian
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5682677/
https://ncbi.nlm.nih.gov/pubmed/29072691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.512
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados